Comments on 'Fixed vs random effects meta-analysis in rare event studies: The rosiglitazone link with myocardial infarction and cardiac death'

Statistics in Medicine

Volumn 27, Issue 19, 2008, Pages 3910-3912

  Carpenter, James ^a   Rücker, Gerta ^a   Schwarzer, Guido ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ROSIGLITAZONE;

CLINICAL TRIAL; CONFIDENCE INTERVAL; DATA ANALYSIS; HEART DEATH; HEART INFARCTION; HUMAN; LETTER; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; MEDICAL RESEARCH; OUTCOME ASSESSMENT; SAMPLE SIZE; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; SYSTEMATIC ERROR; TREATMENT OUTCOME; VARIANCE;

HUMANS; HYPOGLYCEMIC AGENTS; META-ANALYSIS AS TOPIC; MODELS, STATISTICAL; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; THIAZOLIDINEDIONES;

EID: 50449090802     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3173     Document Type: Letter

References (2)

1. Shuster JJ, Jones LS, Salmon DA. Fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death. Statistics in Medicine 2007; 26:4375-4385.
2. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986; 7:177-188.